NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Shares of Virgin Galactic (NYSE:SPCE) surged 10% in premarket trading, while Rocket Lab (NASDAQ:RKLB) rose 3.5%, and Boeing (NYSE:BA) saw a modest 0.5% uptick. The movement comes after an analyst ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Science Natural Supplements Berberine Sets New Standard for Weight Loss, Blood Sugar, and Gut Health Support NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / In This Article, ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Veteran financial expert Stacy Johnson shares a five-point strategy for navigating market downturns, emphasizing maintaining ...